InnoCan Pharma Corporation INNPF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -35.00K | -972.00K | 2.00M | -1.95M | -590.00K |
| Total Depreciation and Amortization | 5.00K | 8.00K | 12.00K | 11.00K | 9.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -825.00K | 446.00K | -3.69M | 2.11M | -16.00K |
| Change in Net Operating Assets | 392.00K | 12.00K | 1.10M | -153.00K | 1.28M |
| Cash from Operations | -463.00K | -506.00K | -581.00K | 22.00K | 686.00K |
| Capital Expenditure | -9.00K | -- | -6.00K | -4.00K | -1.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 1.00K | -- | -1.00K |
| Cash from Investing | -9.00K | -- | -5.00K | -4.00K | -2.00K |
| Total Debt Issued | 200.00K | 450.00K | 0.00 | 0.00 | 0.00 |
| Total Debt Repaid | -- | -- | 0.00 | -3.00K | -4.00K |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 93.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | 64.00K |
| Cash from Financing | 200.00K | 450.00K | 0.00 | -3.00K | 153.00K |
| Foreign Exchange rate Adjustments | 44.00K | -4.00K | 3.00K | 0.00 | 53.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -228.00K | -60.00K | -583.00K | 15.00K | 890.00K |